{"id":84128,"date":"2026-09-12T16:10:51","date_gmt":"2026-09-12T10:40:51","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/"},"modified":"2026-09-12T21:23:46","modified_gmt":"2026-09-12T15:53:46","slug":"entheon-adopts-semi-annual-reporting","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/","title":{"rendered":"Entheon Adopts Semi-Annual Reporting"},"content":{"rendered":"

<\/p>\n

Vancouver, British Columbia–(Newsfile Corp. – September 11, 2026) – Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (“Entheon<\/b>” or the “Company<\/b>“) announces that it has elected to participate in the Coordinated Blanket Order 51-933 \u2013 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the “Blanket Order<\/b>“), issued by the Canadian Securities Administrators, and adopts semi-annual financial reporting. This news release is being filed pursuant to the Blanket Order.<\/p>\n

The Blanket Order is a pilot program that permits eligible venture issuers to voluntarily move from quarterly to semi-annual financial reporting. The Company has determined that it meets the eligibility criteria under the Blanket Order, including that it is a venture issuer, has annual revenue of less than $10 million, has a disclosure record of over 12 months, and has filed all required periodic and timely disclosure documents.<\/p>\n

As a result of this election, the Company will file interim financial reports and associated management’s discussion and analysis (“MD&A”) on a semi-annual basis, rather than quarterly. The Company’s fiscal year-end is November 30 and will continue to file annual audited financial statements (due within 120 days of November 30). The Company will continue to remain subject to timely disclosure requirements and will continue to report all material changes and significant developments in accordance with National Instrument 51-102\u00a0\u2013\u00a0Continuous Disclosure Obligations.<\/p>\n

Under the Blanket Order, the Company will be exempt from filing interim financial reports and associated MD&A for its first and third quarters. The initial period for which the Company will not file a quarterly interim financial report and associated MD&A will be for the three and nine months ended August 31, 2026. The Company will file its next financial report for the year ended November 30, 2026 (due within 120 days of November 30, 2026). Should the Company cease to continue participating in the Blanket Order, it will announce it in a future news release.<\/p>\n

About Entheon Biomedical Corp.<\/b>
\nEntheon is a biotechnology research and development company interested in treating addiction and substance use disorders.<\/p>\n

On Behalf of the Board of Directors,<\/b>
\nTimothy Ko, CEO and Director<\/p>\n

\n

For more information, please contact the Company at:
\nEntheon Biomedical Corp.
\nTimothy Ko, CEO
\n1 (604) 562-3932
\ntimothy@entheonbiomedical.com<\/a>
\nhttps:\/\/entheonbiomedical.com<\/a><\/p>\n<\/div>\n

To view the source version of this press release, please visit https:\/\/www.newsfilecorp.com\/release\/314082<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Vancouver, British Columbia–(Newsfile Corp. – September 11, 2026) – Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) announces that it has elected to participate in the Coordinated Blanket Order 51-933 \u2013 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the “Blanket Order“), issued by the Canadian Securities Administrators, and …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32016],"tags":[34026],"class_list":["post-84128","post","type-post","status-publish","format-standard","","category-press-releases","tag-entheon-biomedical-corp"],"yoast_head":"\nEntheon Adopts Semi-Annual Reporting - Matribhumi Samachar English<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entheon Adopts Semi-Annual Reporting - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Vancouver, British Columbia–(Newsfile Corp. – September 11, 2026) – Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) announces that it has elected to participate in the Coordinated Blanket Order 51-933 \u2013 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the “Blanket Order“), issued by the Canadian Securities Administrators, and …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-12T10:40:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-12T15:53:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/api.newsfilecorp.com\/newsinfo\/314082\/511\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/\",\"name\":\"Entheon Adopts Semi-Annual Reporting - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2026-09-12T10:40:51+00:00\",\"dateModified\":\"2026-09-12T15:53:46+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entheon Adopts Semi-Annual Reporting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entheon Adopts Semi-Annual Reporting - Matribhumi Samachar English","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/","og_locale":"en_US","og_type":"article","og_title":"Entheon Adopts Semi-Annual Reporting - Matribhumi Samachar English","og_description":"Vancouver, British Columbia–(Newsfile Corp. – September 11, 2026) – Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) announces that it has elected to participate in the Coordinated Blanket Order 51-933 \u2013 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the “Blanket Order“), issued by the Canadian Securities Administrators, and …","og_url":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2026-09-12T10:40:51+00:00","article_modified_time":"2026-09-12T15:53:46+00:00","og_image":[{"url":"https:\/\/api.newsfilecorp.com\/newsinfo\/314082\/511"}],"author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/","url":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/","name":"Entheon Adopts Semi-Annual Reporting - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2026-09-12T10:40:51+00:00","dateModified":"2026-09-12T15:53:46+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/09\/12\/entheon-adopts-semi-annual-reporting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"Entheon Adopts Semi-Annual Reporting"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/84128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=84128"}],"version-history":[{"count":1,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/84128\/revisions"}],"predecessor-version":[{"id":84137,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/84128\/revisions\/84137"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=84128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=84128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=84128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}